Format

Send to

Choose Destination
Exp Mol Med. 2019 Dec 19;51(12):160. doi: 10.1038/s12276-019-0286-3.

Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm.

Author information

1
Department of Physiology, Cardiovascular Research Center, University of Alberta, Edmonton, AB, Canada.
2
Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
3
Department of Physiology, Cardiovascular Research Center, University of Alberta, Edmonton, AB, Canada. z.kassiri@ualberta.ca.

Abstract

Aortic aneurysm is an asymptomatic disease with dire outcomes if undiagnosed. Aortic aneurysm rupture is a significant cause of death worldwide. To date, surgical repair or endovascular repair (EVAR) is the only effective treatment for aortic aneurysm, as no pharmacological treatment has been found effective. Aortic aneurysm, a focal dilation of the aorta, can be formed in the thoracic (TAA) or the abdominal (AAA) region; however, our understanding as to what determines the site of aneurysm formation remains quite limited. The extracellular matrix (ECM) is the noncellular component of the aortic wall, that in addition to providing structural support, regulates bioavailability of an array of growth factors and cytokines, thereby influencing cell function and behavior that ultimately determine physiological or pathological remodeling of the aortic wall. Here, we provide an overview of the ECM proteins that have been reported to be involved in aortic aneurysm formation in humans or animal models, and the experimental models for TAA and AAA and the link to ECM manipulations. We also provide a comparative analysis, where data available, between TAA and AAA, and how aberrant ECM proteolysis versus disrupted synthesis may determine the site of aneurysm formation.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center